Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use

EP Calandre, F Rico-Villademoros… - Expert review of …, 2016 - Taylor & Francis
Introduction: The first two alpha2delta ligands–gabapentin (GBP) and pregabalin (PGB)–
were initially synthesized as antiepileptics; however, they were later also found to be useful …

Pregabalin: its pharmacology and use in pain management

NM Gajraj - Anesthesia & Analgesia, 2007 - journals.lww.com
Pregabalin is a new synthetic molecule and a structural derivative of the inhibitory
neurotransmitter γ-aminobutyric acid. It is an α 2-δ (α 2-δ) ligand that has analgesic …

[HTML][HTML] Mirogabalin: first global approval

ED Deeks - Drugs, 2019 - Springer
Mirogabalin besylate (hereafter mirogabalin)[Tarlige®] is an orally administered
gabapentinoid developed by Daiichi Sankyo for the treatment of peripheral neuropathic pain …

Pregabalin in neuropathic pain: evidences and possible mechanisms

V Verma, N Singh, A Singh Jaggi - Current neuropharmacology, 2014 - ingentaconnect.com
Pregabalin is an antagonist of voltage gated Ca2+ channels and specifically binds to alpha-
2-delta subunit to produce antiepileptic and analgesic actions. It successfully alleviates the …

The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview

G Martinotti, M Lupi, F Sarchione… - Current …, 2013 - ingentaconnect.com
Pregabalin is an anticonvulsant drug that binds to the α2δ (alpha2delta) subunit of the
voltage-dependent calcium channel in central nervous system (CNS). Pregabalin decreases …

Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain

C Toth - Therapeutic advances in drug safety, 2014 - journals.sagepub.com
Used mainly for the management of neuropathic pain, pregabalin is a gabapentinoid or
anticonvulsant that was initially developed as an antiepileptic agent. After more than a …

Pregabalin: a novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders

DM Tassone, E Boyce, J Guyer, D Nuzum - Clinical therapeutics, 2007 - Elsevier
BACKGROUND:: The US Food and Drug Administration (FDA) approved pregabalin in
December 2004 for the treatment of neuropathic pain associated with diabetic peripheral …

Pregabalin: from molecule to medicine

R Kavoussi - European Neuropsychopharmacology, 2006 - Elsevier
Pregabalin, a compound with a novel mechanism of action (MOA), has demonstrated
efficacy as an adjunctive treatment for epilepsy and in several neuropathic pain models …

Pregabalin: in the treatment of painful diabetic peripheral neuropathy

JE Frampton, LJ Scott - Drugs, 2004 - Springer
Abstract▴ Pregabalin, the pharmacologically active S-enantiomerof 3-aminomethyl-5-methyl-
hexanoic acid, has a similar pharmacological profile to that of its developmental …

The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?

SM Stahl, F Porreca, CP Taylor, R Cheung… - Trends in …, 2013 - cell.com
Pregabalin is a specific ligand of the alpha 2-delta (α 2-δ) auxiliary subunit of voltage-gated
calcium channels. A growing body of evidence from studies of anxiety and pain indicate that …